Nicole CoustierA clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.
Nicole CoustierNew tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know.
Nicole CoustierWhy do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than the first.
Nicole CoustierFDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after.
Nicole CoustierHospitals are the gatekeepers of device adoption. Learn how to align with their economics.
Nicole CoustierMedTech teams often misunderstand what regulators mean. This article translates FDA and CMS jargon into actionable insights for reimbursement.